Intellia Therapeutics OverviewIntellia Therapeutics Net Income
Profitability analysis for NTLA.
Quarterly Net Income
-$96.23M
↑ 15.83% YoY
As of Mar 2026
Annual Net Income (TTM)
-$394.60M
↑ 24.97% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...